200 related articles for article (PubMed ID: 37435257)
41. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
Mendelowitz AJ
Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
[TBL] [Abstract][Full Text] [Related]
42. Drug therapy for delirium in terminally ill adults.
Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
[TBL] [Abstract][Full Text] [Related]
43. Continuum of care: stabilizing the acutely agitated patient.
Bellnier TJ
Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S12-8. PubMed ID: 12227082
[TBL] [Abstract][Full Text] [Related]
44. A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department.
Martel ML; Klein LR; Rivard RL; Cole JB
Acad Emerg Med; 2016 Jan; 23(1):29-35. PubMed ID: 26720055
[TBL] [Abstract][Full Text] [Related]
45. Calming versus sedative effects of intramuscular olanzapine in agitated patients.
Battaglia J; Lindborg SR; Alaka K; Meehan K; Wright P
Am J Emerg Med; 2003 May; 21(3):192-8. PubMed ID: 12811711
[TBL] [Abstract][Full Text] [Related]
46. Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).
Kurisu K; Inada S; Maeda I; Nobata H; Ogawa A; Iwase S; Uchida M; Akechi T; Amano K; Nakajima N; Morita T; Sumitani M; Yoshiuchi K
Support Care Cancer; 2024 Feb; 32(3):147. PubMed ID: 38326487
[TBL] [Abstract][Full Text] [Related]
47. Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.
Wilson MP; MacDonald K; Vilke GM; Feifel D
J Emerg Med; 2012 Nov; 43(5):889-96. PubMed ID: 20542400
[TBL] [Abstract][Full Text] [Related]
48. Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical Trial.
Taylor DM; Yap CYL; Knott JC; Taylor SE; Phillips GA; Karro J; Chan EW; Kong DCM; Castle DJ
Ann Emerg Med; 2017 Mar; 69(3):318-326.e1. PubMed ID: 27745766
[TBL] [Abstract][Full Text] [Related]
49. Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.
Kittipeerachon M; Chaichan W
Schizophr Res; 2016 Oct; 176(2-3):231-238. PubMed ID: 27461399
[TBL] [Abstract][Full Text] [Related]
50. A Retrospective Comparison of the Effectiveness and Safety of Intravenous Olanzapine Versus Intravenous Haloperidol for Agitation in Adult Intensive Care Unit Patients.
Wang M; Yankama TT; Abdallah GT; Eche IJ; Knoph KN; Wong A; Patel P; Hsu D; Eche IM
J Intensive Care Med; 2022 Feb; 37(2):222-230. PubMed ID: 33426981
[TBL] [Abstract][Full Text] [Related]
51. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Kohen I; Preval H; Southard R; Francis A
Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
[TBL] [Abstract][Full Text] [Related]
52. Haloperidol plus promethazine for psychosis induced aggression.
Huf G; Alexander J; Allen MH
Cochrane Database Syst Rev; 2005 Jan; (1):CD005146. PubMed ID: 15654706
[TBL] [Abstract][Full Text] [Related]
53. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
Veser FH; Veser BD; McMullan JT; Zealberg J; Currier GW
J Psychiatr Pract; 2006 Mar; 12(2):103-8. PubMed ID: 16728906
[TBL] [Abstract][Full Text] [Related]
54. Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department.
Martel ML; Driver BE; Miner JR; Biros MH; Cole JB
Acad Emerg Med; 2021 Apr; 28(4):421-434. PubMed ID: 32888340
[TBL] [Abstract][Full Text] [Related]
55. Agitated Psychiatric Patient.
Pabst BM; Leung C; Frey JA; Yee J
J Educ Teach Emerg Med; 2020 Oct; 5(4):S59-S83. PubMed ID: 37465334
[TBL] [Abstract][Full Text] [Related]
56. A Prospective Study of Intramuscular Droperidol or Olanzapine for Acute Agitation in the Emergency Department: A Natural Experiment Owing to Drug Shortages.
Cole JB; Stang JL; DeVries PA; Martel ML; Miner JR; Driver BE
Ann Emerg Med; 2021 Aug; 78(2):274-286. PubMed ID: 33846015
[TBL] [Abstract][Full Text] [Related]
57. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
[TBL] [Abstract][Full Text] [Related]
58. [Rapid tranquillisation; review of the literature and recommendations].
Bak M; van Os J; Marcelis M
Tijdschr Psychiatr; 2011; 53(10):727-37. PubMed ID: 21989751
[TBL] [Abstract][Full Text] [Related]
59. Best clinical practice with ziprasidone IM: update after 2 years of experience.
Zimbroff DL; Allen MH; Battaglia J; Citrome L; Fishkind A; Francis A; Herr DL; Hughes D; Martel M; Preval H; Ross R
CNS Spectr; 2005 Sep; 10(9):1-15. PubMed ID: 16247923
[TBL] [Abstract][Full Text] [Related]
60. Ketamine as a first-line treatment for severely agitated emergency department patients.
Riddell J; Tran A; Bengiamin R; Hendey GW; Armenian P
Am J Emerg Med; 2017 Jul; 35(7):1000-1004. PubMed ID: 28237385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
